Sutab - (1.479 g/ 0.225 g/ 0.188 g; Tablet)

Generic Name	Sodium Sulfate, Magnesium Sulfate and Potassium Chloride	Innovator	Braintree Laboratories
Dosage	1.479 g/ 0.225 g/ 0.188 g; Tablet	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	Less Than 5	Tentative Approvals	None
Final Approvals	None	Generic Launches	None
Indication	SUTAB is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*****	*** \ *********	*** **, ****	*******	****	*** ****** *** ****

Chronology Of Events